Data for: Circulating miR-143-3p inhibition protects against insulin resistance in Metabolic Syndrome via targeting of the insulin-like growth factor 2 receptor

Name: Data for: Circulating miR-143-3p inhibition protects against insulin resistance in Metabolic Syndrome via targeting of the insulin-like growth factor 2 receptor
Creator: Hong Li
Published: 2021-04-26T20:30:04.816Z
Keywords: Biographical Data

Li, Hong

doi:10.17632/kfxvjj5j5d.1

Data for: Circulating miR-143-3p inhibition protects against insulin resistance in Metabolic Syndrome via targeting of the insulin-like growth factor 2 receptor

Published: 26 April 2021| Version 1 | DOI: 10.17632/kfxvjj5j5d.1

Contributor:

Hong Li

Description

Circulating miR-143-3p inhibition protects against insulin resistance in Metabolic Syndrome via targeting of the insulin-like growth factor 2 receptor

Data for: Circulating miR-143-3p inhibition protects against insulin resistance in Metabolic Syndrome via targeting of the insulin-like growth factor 2 receptor

Description

Files

Categories

Licence